Trial Profile
Randomized Placebo Controlled Phase II Cross Over Study on the Influence of Triflusal on Cognitive Functions in Healthy Participants
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Triflusal (Primary)
- Indications Thromboembolism; Thrombosis
- Focus Therapeutic Use
- Acronyms Tribunal-Basel
- 09 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Jan 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 25 Dec 2014 New trial record